According to research reviewed by Gram, intradialytic parenteral nutrition, which delivers protein and calories through the dialysis circuit during treatment, is supported for carefully selected hemodialysis patients with protein-energy wasting. Larger trials are still needed to define the best candidates, dosing, and duration.
Many people on dialysis lose muscle and body weight over time, a condition called protein-energy wasting. Eating enough can be hard when appetite is low, food is limited, or diet rules are strict. A 2026 narrative review published in the Journal of Renal Nutrition examined a method called intradialytic parenteral nutrition, or IDPN, which delivers protein and calories through the existing dialysis circuit during treatment. According to research reviewed by Gram, the authors concluded that IDPN is supported for carefully selected patients. The review also noted that larger, well-designed studies are still needed to identify the best candidates, the right doses, and how long treatment should last.
Key Statistics
A 2026 narrative review published in the Journal of Renal Nutrition, which searched PubMed, MEDLINE, and the Cochrane Library through August 2026, concluded that intradialytic parenteral nutrition is supported in carefully selected patients with protein-energy wasting.
Protein-energy wasting is common in people receiving maintenance hemodialysis and is linked to frailty, hospitalization, mortality, poorer quality of life, and reduced transplant readiness, according to a 2026 review in the Journal of Renal Nutrition.
The Quick Take
- What they studied: Researchers asked whether giving nutrition through the dialysis machine during treatment can help people on dialysis who are losing muscle and weight because they cannot eat enough.
- Who participated: This was a review of existing published research rather than a new study with its own group of participants. The sample size was not specified, and the review looked at medical studies, expert consensus statements, and clinical guidelines about adults on maintenance hemodialysis.
- Key finding: The review found that intradialytic parenteral nutrition is supported for carefully selected patients with protein-energy wasting. Because this is a narrative review, it summarizes the evidence rather than calculating a single combined statistic, so the strength of support varies by question and by study.
- What it means for you: If you are on dialysis and struggle to eat enough, this option may be worth discussing with your kidney care team. It is not a fit for everyone, and any decision should be based on your own medical history, lab results, and a conversation with your doctor or dietitian.
The Research Details
This paper is a narrative review, which means the authors read and summarized existing research instead of running a new experiment. They searched major medical databases, including PubMed, MEDLINE, and the Cochrane Library, through August 2026. They also looked at some sources that are not indexed in those databases, such as conference reports.
The authors focused on randomized trials, consensus statements, and clinical practice guidelines. These types of sources are generally considered more reliable than single observations because they compare groups and reflect the views of expert panels. The review then organized what it found around several themes: how protein-energy wasting develops in the body, how hard it is to diagnose, what evidence exists for IDPN, and what questions remain about safety, cost, and transplant readiness.
Because the review pulls together many sources, it provides a broad picture of the field. It does not follow a strict, pre-defined method for combining numbers from each study, so readers should view it as an expert summary rather than a precise statistical measurement.
Narrative reviews are useful when a topic is complex and the evidence comes from many different types of studies. Protein-energy wasting involves inflammation, appetite changes, dialysis itself, and social factors such as food access, so no single trial can explain the whole picture. A broad review helps clinicians see how these pieces fit together.
The review also helps separate what is well supported from what is still uncertain. This matters for patients and clinicians who need to know whether a new approach is ready for routine use or still experimental.
The review was published in a respected peer-reviewed nutrition journal focused on kidney health. Its search covered major databases and included randomized trials and clinical guidelines, which adds credibility.
However, a narrative review does not follow the strict rules of a systematic review or meta-analysis. Its selection of sources is not fully standardized, and it does not calculate a combined effect size. Readers should treat its conclusions as expert guidance that points toward promising options while calling for more research.
What the Results Show
Protein-energy wasting is a condition in which the body loses muscle and stored energy, often seen in people on long-term hemodialysis. It is linked to weakness, frailty, hospital stays, lower quality of life, and a higher risk of death. Eating more by mouth is the usual first step, but many patients cannot meet their needs because of low appetite, inflammation, the body breaking down its own tissue during dialysis, diet restrictions, or limited access to food.
Intradialytic parenteral nutrition, or IDPN, offers an alternative. Nutrients are delivered directly into the bloodstream through the same access line used for dialysis, so no extra needles are typically required. The review describes this as a practical and noninvasive way to add protein and calories during treatment.
The review concludes that current evidence supports IDPN in carefully selected patients with protein-energy wasting. The phrase carefully selected matters. The authors suggest that the benefits may depend on which patients are chosen, how much nutrition is given, and how long it continues.
The review also makes clear that important questions remain open. Researchers still need to determine who benefits most, the best dosing and duration, and whether IDPN improves long-term outcomes such as survival, hospital visits, and quality of life.
The review discusses how IDPN may fit into kidney transplant planning. Patients who are better nourished may be in stronger physical condition, which could matter when they are considered for transplant. The authors present this as an area that deserves further study rather than a proven benefit.
The review also touches on safety and cost. IDPN carries recognized risks that must be managed by a care team, including issues related to infection and metabolic changes. Cost and access are also important, since specialized nutrition support is not equally available to all patients. These points suggest that IDPN decisions should weigh both the medical benefits and the practical burden.
Finally, the review highlights diagnostic challenges. Because protein-energy wasting can be hard to measure precisely, clinicians may struggle to identify the patients who would benefit most. Better diagnostic tools could help match the right patients with the right treatment.
The review fits within a broader shift in kidney care toward treating nutrition as a core part of dialysis rather than an afterthought. Earlier guidance has long emphasized oral nutrition as the first-line approach, and this review keeps that foundation in place. IDPN is positioned as an option for patients who cannot reach their goals through eating alone.
The authors draw on randomized trials, consensus statements, and clinical guidelines, which generally reflect the current expert understanding of the field. Their conclusion that IDPN is supported in selected patients, while larger trials are still needed, is consistent with a cautious, evidence-based approach rather than a sweeping new recommendation.
The most important limitation is the study design. This is a narrative review, so it summarizes earlier work instead of testing a new hypothesis. It does not provide a pooled statistic showing exactly how much IDPN improves outcomes, and it does not state a sample size.
The review’s conclusions are also limited by the quality and size of the underlying research. The authors themselves note that larger trials are needed to define the best candidates, dosing, duration, and effects on clinical outcomes. Some supporting studies may be small, short, or conducted in specific settings, which makes results harder to apply broadly.
Finally, the review reflects the authors’ selection and interpretation of evidence. Readers should consider it a helpful guide to current thinking rather than a final answer.
The Bottom Line
Oral nutrition remains the first-line approach for people on dialysis who are losing weight or muscle. For selected patients who still cannot meet their needs, IDPN is supported by the current evidence reviewed by the authors. Confidence in this recommendation is moderate, because it rests on a narrative review and the authors call for larger trials to confirm the details. Patients should discuss the option with their kidney team before making any change.
People on maintenance hemodialysis who have signs of protein-energy wasting, such as unintended weight loss, low appetite, or muscle weakness, may want to ask their care team about IDPN. Kidney care teams, dietitians, and transplant planners may also find the review useful.
People who are not on dialysis, who do not have protein-energy wasting, or who have conditions that make nutrition support unsafe should not assume this approach applies to them. Anyone considering IDPN should be evaluated by a qualified medical team.
Any benefit from improved nutrition typically develops over weeks to months rather than days, since rebuilding muscle and stabilizing body weight takes time. The review does not provide a precise timeline for IDPN, and the authors note that the best duration is still unclear. Patients should ask their care team how progress will be measured, such as through weight, lab markers, strength, and appetite.
Frequently Asked Questions
What is intradialytic parenteral nutrition?
Intradialytic parenteral nutrition, or IDPN, is a method of delivering protein and calories directly into the bloodstream during dialysis through the existing treatment circuit. A 2026 review describes it as a practical, noninvasive option for patients who cannot meet their nutrition needs by eating alone.
Who might benefit from IDPN on dialysis?
A 2026 narrative review suggests IDPN may help carefully selected dialysis patients with protein-energy wasting, a condition involving muscle and energy loss. The review notes that larger trials are still needed to clearly identify which patients benefit most.
Is nutrition through dialysis a replacement for eating food?
No, oral nutrition remains the first-line approach for dialysis patients. Research reviewed in 2026 describes IDPN as an option for people who still cannot reach their protein and calorie goals through eating, and it should be decided with a kidney care team.
Why do dialysis patients lose muscle and weight?
Protein-energy wasting can be driven by low appetite, inflammation, dialysis-related breakdown of body tissue, diet restrictions, and limited food access. A 2026 review in the Journal of Renal Nutrition links this condition to frailty, hospital stays, and higher mortality.
Want to Apply This Research?
- Track your body weight at the same time each week, ideally before dialysis, and record the number. Also log how many of your daily meals or snacks you finished, using a simple scale such as full, half, or little. Share the trend with your dialysis team at each visit.
- Use the app to set a small daily protein goal that your dietitian approves, and log one protein-rich food at each meal. If your care team starts IDPN, record the treatment days and any side effects, such as nausea, fever, or discomfort at the access site, and report concerns promptly.
- Build a long-term view by logging weight, appetite, energy level, and any hospital visits each month. Review trends every three months with your kidney team to see whether nutrition changes are helping. Keep notes on lab results and transplant-related discussions so your full care history is in one place.
This article summarizes a narrative review of existing research and is provided for general information only. It is not medical advice and does not replace guidance from your kidney care team, dietitian, or physician. Nutrition support through dialysis carries medical risks and is not appropriate for everyone. Do not start, stop, or change any nutrition plan or treatment without speaking to a qualified healthcare provider.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.